Sun, May 19, 2013, 3:00 PM EDT - U.S. Markets closed
The Medicines Co is licensing the rights to a powerful type of cholesterol-lowering drug from Alnylam Pharmaceuticals Inc, entering one of the hottest races in the industry.
Sentiment: Strong Buy